According to recent studies, the most of RA-promoting properties of IL-17 occurs from its synergistic effects with other cytokines (most importantly with TNF-α [105]) during the early stages of affliction establishment, forming self-perpetuating loops of pro-inflammatory activators and effectors [106]. The gene discussed is IL17A; the disease is rheumatoid arthritis.